longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Arm

ARM

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI
  • Weekly Recap | Arm +5.04%, closing in on record highs

    Weekly Review·Sep 12 at 05:58 AM
    - Arm stock rose 5.04 % this week to close at 264.79 USD, outperforming the S & P 500 while exhibiting wide fluctuations driven by AI edge-computing developments and ecosystem expansions. - Forty-three institutions maintain a consensus buy rating with an average target price of 289.205 USD, though significant valuation divergences and high price-to-earnings ratios persist. - Future performance relies on whether AI narratives can successfully translate into actual financial results, with the upcoming November 4 earnings report serving as the primary validation point.
    ARM+1.18%ARMG+2.45%
  • Weekly Recap | Arm +5.45%, Samsung AI deal drives rebound

    Weekly Review·Sep 5 at 06:13 AM
    - Arm accumulated a 5.45 % weekly gain to close at 252.09 USD, outperforming the S&P 500. - Executive share sales initially pressured prices mid-week, but Samsung's collaboration on next-generation edge AI chips drove a strong Friday rebound. - Forty-two institutions gave Arm a consensus buy rating with a target price of 288.36 USD, while upcoming macroeconomic data and AI partnership progress remain key focuses.
    ARM+1.18%ARMG+2.45%
  • Weekly Recap | Arm -1.75%, IBM mainframe tie-up in focus

    Weekly Review·Aug 29 at 05:15 AM
    - Arm closed the week at $239.05, down 1.75% with a weekly amplitude of 14.56%. - Key drivers included IBM mainframe ecosystem cooperation expectations and fluctuating market concerns over AI infrastructure costs. - Forty-two institutions maintained a consensus buy rating with an average target price of $286.44.
    ARM+1.18%ARMG+2.45%